NO20002013D0 - Suspension packaging cell lines for retroviral vectors - Google Patents

Suspension packaging cell lines for retroviral vectors

Info

Publication number
NO20002013D0
NO20002013D0 NO20002013A NO20002013A NO20002013D0 NO 20002013 D0 NO20002013 D0 NO 20002013D0 NO 20002013 A NO20002013 A NO 20002013A NO 20002013 A NO20002013 A NO 20002013A NO 20002013 D0 NO20002013 D0 NO 20002013D0
Authority
NO
Norway
Prior art keywords
cell lines
retroviral vectors
packaging cell
suspension
suspension packaging
Prior art date
Application number
NO20002013A
Other languages
Norwegian (no)
Other versions
NO20002013L (en
Inventor
Stefan Seeber
Stefan Koch
Thorsten Gutjahr
Ulrich Steegmans
Ruediger Rueger
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of NO20002013D0 publication Critical patent/NO20002013D0/en
Publication of NO20002013L publication Critical patent/NO20002013L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051—Methods of production or purification of viral material
    • C12N2740/13052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a packing cell line fully growing in a suspension, which is transfected with a retrovirus plasmid or transduced with a retrovirus vector. The invention aslo relates to a method for the production of said cell lines from suspension cell lines or adheringly growing cell lines.
NO20002013A 1997-10-25 2000-04-17 Suspension packaging cell lines for retroviral vectors NO20002013L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97118583 1997-10-25
EP97121724 1997-12-10
PCT/EP1998/006714 WO1999021967A1 (en) 1997-10-25 1998-10-22 Suspension packing cell lines for retrovirus vectors

Publications (2)

Publication Number Publication Date
NO20002013D0 true NO20002013D0 (en) 2000-04-17
NO20002013L NO20002013L (en) 2000-04-17

Family

ID=26145852

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002013A NO20002013L (en) 1997-10-25 2000-04-17 Suspension packaging cell lines for retroviral vectors

Country Status (16)

Country Link
EP (1) EP1025207B1 (en)
JP (1) JP3517399B2 (en)
KR (1) KR100359542B1 (en)
CN (1) CN1277631A (en)
AT (1) ATE304048T1 (en)
AU (1) AU729986B2 (en)
BR (1) BR9812960A (en)
CA (1) CA2306634C (en)
DE (1) DE59813048D1 (en)
ES (1) ES2248920T3 (en)
HU (1) HUP0004240A2 (en)
IL (1) IL135541A (en)
NO (1) NO20002013L (en)
NZ (1) NZ503827A (en)
TR (1) TR200001125T2 (en)
WO (1) WO1999021967A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100507794B1 (en) * 2003-02-11 2005-08-17 한미약품 주식회사 Method for preparing concentrated retroviral particle dispersion
EP1739180A1 (en) * 2005-06-27 2007-01-03 Max-Delbrück-Centrum für Molekulare Medizin (MDC) T cell line-based packaging cell line for the production of retroviruses by enriching of CD3 expressing cells
EP3546583A1 (en) * 2009-06-17 2019-10-02 Tocagen Inc. Producer cells for replication competent retroviral vectors
CN111286517A (en) * 2018-12-07 2020-06-16 珠海联邦制药股份有限公司 A kind of packaging method of replication-defective retrovirus and its application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4059485A (en) * 1976-11-03 1977-11-22 Monsanto Company Adaptation of cell lines to suspension culture
RU1347448C (en) * 1985-09-27 1995-04-10 Институт полиомиелита и вирусных энцефалитов Российской АМН Strain taurus-1 of heteroploid cells of calf kidney used for virus cultivation
WO1990005180A1 (en) * 1988-10-31 1990-05-17 The Regents Of The University Of California Products and methods for controlling the suppression of the neoplastic phenotype
DE19612966B4 (en) * 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK cells and methods of propagating influenza viruses

Also Published As

Publication number Publication date
IL135541A0 (en) 2001-05-20
CN1277631A (en) 2000-12-20
ATE304048T1 (en) 2005-09-15
AU729986B2 (en) 2001-02-22
AU1231399A (en) 1999-05-17
EP1025207A1 (en) 2000-08-09
NZ503827A (en) 2001-06-29
CA2306634A1 (en) 1999-05-06
JP3517399B2 (en) 2004-04-12
CA2306634C (en) 2005-04-12
BR9812960A (en) 2000-08-08
DE59813048D1 (en) 2005-10-13
WO1999021967A1 (en) 1999-05-06
EP1025207B1 (en) 2005-09-07
NO20002013L (en) 2000-04-17
JP2001520879A (en) 2001-11-06
KR100359542B1 (en) 2002-10-31
IL135541A (en) 2004-02-19
TR200001125T2 (en) 2000-09-21
KR20010031387A (en) 2001-04-16
ES2248920T3 (en) 2006-03-16
HUP0004240A2 (en) 2001-03-28

Similar Documents

Publication Publication Date Title
WO1995030763A3 (en) Retroviral vectors having a reduced recombination rate
AU2998597A (en) Crossless retroviral vectors
EP1285967A3 (en) Human retroviral packaging cell line
WO1999004026A3 (en) Lentiviral vectors
WO1997007225A3 (en) High efficiency retroviral packaging system
CO4230241A1 (en) BICYCLE COMPOUNDS USEFUL AS GLYCOPROTEIN IIb / IIIa ANTAGONISTS
MY125594A (en) Immortalized cell lines for virus growth
TW376409B (en) Stabilizer mixture
WO1989007136A3 (en) Modified hepatocytes and uses therefor
MY149862A (en) Compounds useful to treat retroviral infections
AU7545500A (en) Producer cell for the production of retroviral vectors
MY108663A (en) Liquid detergent compositions containing a suspended peroxygen bleach
ES2128457T5 (en) METALOCENOS WITH SILILO BRIDGE AND ITS USE.
GB2325003A (en) Rectroviral vectors
GR3027657T3 (en) N-alkylthio polyamine derivatives as radioprotective agents
DE59813048D1 (en) SUSPENSION PACKAGING CELL LINES FOR RETROVIRUS VECTORS
WO2000040741A3 (en) Lentivirus vector system
FR2730735B1 (en) AMPLIFIER SEQUENCES, VECTORS CARRYING SUCH SEQUENCES AND THEIR USES IN COMPOSITIONS FOR THE EXPRESSION OF NUCLEOTIDE SEQUENCES IN TRANSFECTED CELLS, THERAPEUTIC AND VACCINE APPLICATIONS
DK0801575T3 (en) Retroviral vectors for expression in embryonic cells
AU6139699A (en) Packaging cell lines for hiv-derived retroviral vector particles
DE69414109D1 (en) PROSTAGLANDIN RECEPTOR EP3 AND ENCODING DNA
DK1097233T3 (en) Promoter for growth differentiation factor and applications thereof
AU5274696A (en) Pseudotyped retroviral particles
ATE226638T1 (en) RETROVIRAL VECTOR AND ITS USE IN GENE THERAPY
AR020076A1 (en) ANPHOTROPIC RETROVIRUS PACKAGING CELL LINE, PROCESS FOR ITS PRODUCTION, AND PROCESS FOR THE PRODUCTION OF A RETROVIRAL VECTOR THROUGH THE SAME.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application